Enrollment | Treatment | Post-TIPS follow-up | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Evaluation/examination | ≤14 days before randomization | D0 | D1 | D2 | M1 | M3 | M6 | M12 | M18 | M24 |
Informed consent | × | |||||||||
Demographics | × | |||||||||
Medical History | × | |||||||||
Enhanced abdominal CT | × | × | × | × | × | |||||
Ultrasound Elastography | × | × | × | × | × | × | × | × | ||
Upper gastrointestinal endoscopy | × | × | × | × | × | × | × | |||
Hematologya | × | × | × | × | × | × | × | × | × | |
Biochemistryb | × | × | × | × | × | × | × | × | ||
Serial ammonia concentration | × | × | × | × | × | × | × | × | ||
Tumor markersc | × | × | × | × | × | × | × | × | ||
HBV-DNA | × | × | × | × | × | × | × | × | ||
Child-Pugh | × | × | × | × | × | × | × | × | ||
MELDd | × | × | × | × | × | × | × | × | ||
ECOGe | × | × | × | × | × | × | × | × | × | × |
HE assessmentf | × | × | × | × | × | × | × | × | × | × |
Adverse events | × | × | × | × | × | × | × | × | × | × |
Survival | × | × | × | × | × | × | × | × | × | × |